(Q40170841)

18 September 2017

title

CD83 expression on dendritic cells and T cells: correlation with effective immune responses (English)

1 reference

18 September 2017

1 reference

8

1 reference

18 September 2017

7

Kris Thielemans

1 reference

18 September 2017

Cindy Aerts-Toegaert

1

1 reference

18 September 2017

Carlo Heirman

2

1 reference

18 September 2017

Sandra Tuyaerts

3

1 reference

18 September 2017

Jurgen Corthals

4

1 reference

18 September 2017

Joeri L Aerts

5

1 reference

18 September 2017

Aude Bonehill

6

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

European Journal of Immunology

18 September 2017

published in

1 reference

18 September 2017

volume

37

1 reference

18 September 2017

issue

3

1 reference

18 September 2017

page(s)

686-695

1 reference

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Dendritic cells: specialized and regulated antigen processing machines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Dendritic cell vaccines for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Enhanced activation of CD83-positive T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Transcription factor NF-kappaB regulates inducible CD83 gene expression in activated T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

CD83 localization in a recycling compartment of immature human monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

CD83 is an I-type lectin adhesion receptor that binds monocytes and a subset of activated CD8+ T cells [corrected].

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Viral vectors for dendritic cell-based immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Cutting edge: CD83 regulates the development of cellular immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Alternative splicing generates putative soluble CD83 proteins that inhibit T cell proliferation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

The soluble form of CD83 is present at elevated levels in a number of hematological malignancies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Role of CD83 in the immunomodulation of dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

CD83 is a dimer: Comparative analysis of monomeric and dimeric isoforms

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

A novel mutation in CD83 results in the development of a unique population of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

CD83 expression influences CD4+ T cell development in the thymus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Generation of large numbers of dendritic cells in a closed system using Cell Factories.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Dendritic cells differentiated in the presence of IFN-β and IL-3 are potent inducers of an antigen-specific CD8+ T cell response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636535

7 January 2021

Identifiers

DOI

10.1002/EJI.200636535

1 reference

18 September 2017

1 reference